Sofia S. Haque, MD

Sofia S. Haque, MD

Neuroradiologist

Clinical Expertise

Neuroradiology; Adult and Pediatric Brain Tumor Imaging

Share

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Monday through Friday, 8:00 a.m. to 6:00 p.m., (Eastern time)
Accepted Insurance Providers

Dr. Haque accepts the following list of insurance providers. Select your insurance provider to see more details.

Aetna

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (City of NY retirees only, starting 7/1/23)

Payor Type:
In Network Coverage Type(s): PPO

Blue Cross Blue Shield Federal Employee Program

Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO

Blue Cross Blue Shield New York

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Blue Cross Blue Shield states outside of NY/NJ

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS

Blue Cross Health Plus

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Carrum Health

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

Cigna

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Connecticare

Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO

Emblem

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO

Emblem Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Emblem Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Empire Blue Cross Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO, DSN

Empire Essential

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Fidelis

Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO

Fidelis Managed Medicaid & HARP

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Fidelis Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO

First Health

Payor Type:
In Network Coverage Type(s): PPO

Healthfirst

Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS

Healthfirst Managed Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO

Healthfirst Medicare Advantage

Payor Type:
In Network Coverage Type(s): HMO, PPO

Healthsmart

Payor Type: Commercial
In Network Coverage Type(s): PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

Payor Type: Commercial
In Network Coverage Type(s): HMO

Horizon Blue Cross Blue Shield New Jersey (PPO)

Payor Type: Commercial
In Network Coverage Type(s): PPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

Payor Type: Commercial
In Network Coverage Type(s): EPO

Horizon Medicare Advantage

Payor Type:
In Network Coverage Type(s): PPO, HMO

Husky CT Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Magnacare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO

Medicare Part A&B (traditional Medicare)

Payor Type:
In Network Coverage Type(s): Federal Government

Multiplan/Beech Street/PHCS

Payor Type: Commercial
In Network Coverage Type(s): Supplemental

MVP

Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP

Non-Participating Plans with Out of Network Benefits

Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

Payor Type:
In Network Coverage Type(s): TBD

Oscar

Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO

Oxford

Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO

Qualcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

Straight NJ Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Straight NY Medicaid

Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government

Tricare

Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO

UMR

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS

United Healthcare

Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO

World Trade Center Health Program (WTC)

Payor Type: Commercial
In Network Coverage Type(s): State Government

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, Emory University School of Medicine

Residencies

University of Virginia Health System; Maimonides Medical Center

Fellowships

NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center

Board Certifications

Diagnostic Radiology; Certificate of Added Qualification in Neuroradiology

I am a board-certified neuroradiologist. My primary interest is pediatric brain tumor imaging. My responsibilities involve reading MRI and CT scans of both adults and children to diagnose cancer in the brain and spine. I also read these images to see if tumor is responding to therapy, and to identify any potential complications of cancer or its treatment. I also perform diagnostic procedures such as lumbar punctures. They can help surgeons and medical oncologists manage the care of people with cancer that has spread or those who have primary brain tumors, leukemia, and lymphoma.

Read more

I have a passion for theranostic research. This involves using imaging not only to diagnose cancer but also to evaluate treatment. I am also involved in research to see how well combined chemotherapy treatments work for metastatic breast cancer as well as head and neck cancer.

In addition, I participate in efforts to develop new antibody therapies for pediatric brain tumors, such as pontine gliomas, neuroblastomas, and medulloblastomas. I have a particular focus on retinoblastoma, a rare pediatric cancer. I am developing new and advanced techniques that can be especially helpful for evaluating tumors that have been historically hard to treat.

I am a member of the Pediatric Neuro-Oncologic Disease Management Team. We integrate the latest advances in medicine, surgery, and diagnostic imaging in patient care and research. For example, I helped develop whole-body MRI screening protocols in people with a known genetic susceptibility due to Li-Fraumeni syndrome and nevoid basal cell carcinoma syndrome. I am also a member of the Brain Tumor Center, the Pediatric Brain Tumor Consortium, and the Children’s Oncology Group.

I oversee the training and education of fellows in neuroradiology. I am excited to participate in their education daily.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Neuroradiology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

D’Ambrosio N, Lyo JK, Young RJ, Haque SS, Karimi S.. Imaging of metastatic CNS neuroblastoma.. AJR Am J Roentgenol. 2010 May;194(5):1223-9. 

D’Ambrosio N, Lyo J, Young R, Haque S, Karimi S.. Common and unusual craniofacial manifestations of metastatic neuroblastoma.. Neuroradiology. 2010 May 4.

Haque SS. Imaging of Lymphoma of the Central Nervous System, Spine, and Orbit. MRI Clinics of North America. February 2010.

Read more

Ney DE, Huse JT, Dunkel IJ, Steinherz PG, Haque S, Khakoo Y.. Intraventricular Meningioma After Cranial Irradiation for Childhood Leukemia.. J Child Neurol. 2010 Mar 5. 

Matthew G. Fury, Sofia Haque, Hilda Stambuk, Ronglai Shen, Diane Carlson, David Pfister. A Phase II Study of Pemetrexed Plus Gemcitabine Every Two Weeks for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)

Haque Sofia, MD “Imaging of Lymphoma of the Central Nervous System, Spine, and Orbit,” Radiologic Clinics of North America. February 2010.

Haque Sofia, MD Douglas E. Ney, MD, Jason T. Huse, MD, Ira J. Dunkel, MD, Peter G. Steinherz, MD, Yasmin Khakoo, MD. Intraventricular Meningioma after Cranial Irradiation for Childhood Leukemia. September 2009.

Young RJ, Haque SS, Lyo J. Toxic and Metabolic Diseases. In: Law M, Naidich TP, Som P, eds. Problem Solving in Neuroradiology Philadelphia, PA: Elsevier 2009.

Haque SS, Law M, Abrey LE, Young RJ. Imaging of Lymphoma of the Central Nervous System, Spine and Orbit Rad Clin N Am Apr 2008; 46:339-361

Allison JW, David PC, Sato Y, James CA, Haque SS, Angtuaco EJ, Glasier CM. Intracranial aneurysms in infants and children. Pediatr Radiol April 1998;28(4):223-9.

 

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Sofia S. Haque discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures